Pacer Advisors »

Maplight Therapeutics shares owned by Pacer Advisors

Quarter-by-quarter ownership of Maplight Therapeutics (MPLT) shares owned by Pacer Advisors from 13F filings

Historical chart of Pacer Advisors investment in Maplight Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Maplight Therapeutics held by Pacer Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maplight Therapeutics by Pacer Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $8.0k 231 34.63

More positions owned by Pacer Advisors

NVIDIA Corp Common Stock - Domestic (NVDA)
Bristol-Myers Squibb Common Stock - Domestic (BMY)
Altria Group Common Stock - Domestic (MO)
Comcast Corp Common Stock - Domestic (CMCSA)
Apple Common Stock - Domestic (AAPL)
Booking Holdings Common Stock - Domestic (BKNG)
Verizon Communications Common Stock - Domestic (VZ)
Pfizer Common Stock - Domestic (PFE)
At&t Common Stock - Domestic (T)
Qualcomm Common Stock - Domestic (QCOM)
Gilead Sciences Common Stock - Domestic (GILD)
HCA Healthcare Common Stock - Domestic (HCA)
Lowe's Cos Common Stock - Domestic (LOW)
Uber Technologies Common Stock - Domestic (UBER)
Newmont Corp Common Stock - Domestic (NEM)

View all positions for Pacer Advisors

Top funds holding Maplight Therapeutics

Novo A/S
Fcpm Iii Services B.v.
Goldman Sachs Group
BlackRock
Nan Fung Group Holdings
5AM Venture Management
Sanofi
FMR
Vanguard Capital Management
Blue Owl Capital Holdings
Paradigm Biocapital Advisors
Pivotal bioVenture Partners Investment Advisor
Velan Capital Investment Management
Siren
Geode Capital Management

View all funds holding Maplight Therapeutics